- €11.50m
- €14.92m
- BGN20.24m
Annual income statement for Etropal AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 11.7 | 6.75 | 11.2 | 15.8 | 20.2 |
| Cost of Revenue | |||||
| Gross Profit | 1.09 | 2.55 | 3.56 | 4.28 | 5.24 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 15.1 | 7.26 | 11 | 15.5 | 19.7 |
| Operating Profit | -3.41 | -0.511 | 0.196 | 0.334 | 0.52 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.46 | -0.783 | -0.13 | 0.045 | 0.218 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.41 | -0.81 | -0.123 | 0.044 | 0.218 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.44 | -0.718 | -0.028 | 0.089 | 0.324 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.44 | -0.718 | -0.028 | 0.089 | 0.324 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.688 | -0.144 | -0.006 | 0.018 | 0.065 |
| Dividends per Share |